Press release
Orphan Diseases Market - Bristol-Myers Squibb, Alexion, Sanofi, Vertex Pharmaceuticals, Merck & Co. and AbbVie
Market Highlight
The global orphan diseases market has been evaluated to be rapidly growing market and it is expected that it will grow at tremendous rate in the future. Orphan diseases are mostly genetic and exists lifelong with the patient; they are also known as rare diseases and affects small number of patient population. About 80% of orphan disease disorders are genetic. Rising consumer awareness and continuous development of treatment for orphan diseases are driving the growth of this market. Major drugs manufacturers are looking positively towards the orphan disease drug segment and investing huge amount in R&D of the same. Many countries are forming norms and acts for the treatment and cure of orphan diseases.
There are several factors which are prohibiting the growth of this market which includes extremely high cost of orphan disease treatment and drugs and absence of correct diagnosis, appropriate treatment, healthcare facilities, and information about the orphan disease disorders etc.
Request for Sample Report@ https://www.marketresearchfuture.com/sample_request/2547
Regional Analysis:
Depending on the geographic region, orphan diseases market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America comprise the largest market share of the global orphan diseases market. Moreover the European market is also growing continuously and slowly catching up with the growth and volume of the American market and is expected to maintain this in the future as well. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the future. Rest of the World is likely to have a limited but steady growth with respect to this market.
Key Player
• Bristol-Myers Squibb Company (US)
• Novartis AG (Switzerland)
• CELGENE CORPORATION (US)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Pfizer Inc. (US)
• Alexion (US)
• Sanofi (France)
• Vertex Pharmaceuticals Incorporated (US)
• GlaxoSmithKline plc. (UK)
• Merck & Co., Inc (US)
• AbbVie Inc. (US)
Segmentation
By Type - Genetic Disorders, Blood Disorders, Cancer, Growth Disorder, Cardiovascular Diseases, Neurological Disorders, Eye Disorders and Others
By Type - Treatment Gene Therapy, Cell Therapy, Drug Therapy and Others
By End User - Hospital and Clinics, Research Laboratory and Others
By Region: North America, Asia-Pacific, Europe and Row
Browse Full OD Market @ https://www.marketresearchfuture.com/reports/orphan-diseases-market-2547
Taste the market data and market information presented in more than 78 market data tables and figures spread in 85 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Orphan Diseases Market Research Report –Global Forecast to 2022.”
Intended Audience
• Hospitals and clinics
• Orphan diseases drug manufacturers and suppliers
• Government and independent regulatory authorities
• Research and development (R&D) companies
• Market research and consulting service providers
• Medical research laboratories
• Potential investors
•
Table of Content
1 Report Prologue
2 Market Introduction
3 Research Methodology
3.1 Research Process
3.2 Primary Research
4 Market Dynamics
4.1 Drivers
4.2 Restraints
5 Market Factor Analysis
5.1 Value/Supply Chain Analysis
5.2 Porter's 5 Forces Analysis
5.3 Pricing Analysis
6 Global Orphan diseases Market Market, By Disease Type (USD Million)
6.1 Autoimmune Disorders
6.2 Genetic Disorders
6.3 Blood Disorders
6.4 Cancer
7 Chronic Disease Management Market, By Treatment Type (USD Million)
7.1 Gene Therapy
7.2 Drug Therapy
7.3 Drug Therapy
8 Global Chronic Disease Management Market, By End User (USD Million)
8.1 Hospitals and Clinics
8.2 Research Laboratories
9 Global Orphan Disease Market, By Region (USD Million)
Continued……
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Akash Anand
Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com
Web: https://www.marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Diseases Market - Bristol-Myers Squibb, Alexion, Sanofi, Vertex Pharmaceuticals, Merck & Co. and AbbVie here
News-ID: 504355 • Views: …
More Releases from Market Research Future
Ophthalmic Topical Therapeutics Market | Global Market Analysis Report - 2035
Ophthalmic Topical Therapeutics: Advancing Eye Care Through Targeted Treatment
Ophthalmic topical therapeutics have become a cornerstone in modern eye care, offering precise, localized treatment for a wide range of ocular conditions. Unlike systemic medications, which circulate throughout the body and may produce unintended side effects, topical therapies deliver active compounds directly to the eye, ensuring higher efficacy and a faster onset of action. This localized approach not only improves treatment outcomes…
Mental Health Apps Market Share, Size, Growth and Forecast to 2035
Mental Health Apps: Transforming the Way We Care for Our Minds
In recent years, mental health has gained increasing recognition as an essential component of overall well-being. Despite growing awareness, many individuals still face barriers to accessing mental health support, including stigma, cost, and geographic limitations. Mental health apps have emerged as a transformative solution, leveraging technology to provide accessible, personalized, and convenient mental health care for millions worldwide.
The Rise of…
Surgical Gloves Market Size, Share, Growth | CAGR of 4.95%
Surgical Gloves: A Critical Component of Modern Healthcare
Surgical gloves have become an indispensable element in modern healthcare, serving as a first line of defense against contamination, infection, and disease transmission. These gloves are not just protective gear-they are a symbol of safety, hygiene, and precision in medical practice. Their significance spans from routine hospital procedures to complex surgical interventions, highlighting their essential role in patient care and medical safety protocols.
The…
Asia Pacific CRO Market Size, Share & Growth Report by 2035
Asia Pacific CRO Market: Driving Innovation and Transformation in the Clinical Research Landscape
The Asia Pacific Contract Research Organization (CRO) market has been witnessing significant growth over the past decade, emerging as a pivotal hub for clinical research and drug development. With a growing population, increasing prevalence of chronic diseases, and rising investments in healthcare infrastructure, the region has become an attractive destination for pharmaceutical and biotechnology companies seeking cost-effective and…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
